Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) EPS (Weighted Average and Diluted) (2016 - 2025)

HealthLynked (HLYK) has disclosed EPS (Weighted Average and Diluted) for 10 consecutive years, with -$0.24 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 45.45% to -$0.24 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.54 through Dec 2025, up 53.04% year-over-year, with the annual reading at -$1.16 for FY2025, 46.79% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.24 at HealthLynked, up from -$0.3 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.01 in Q1 2023, with the low at -$0.7 in Q3 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.09, with a median of -$0.01 recorded in 2022.
  • The sharpest move saw EPS (Weighted Average and Diluted) surged 200.0% in 2023, then tumbled 106153.93% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at -$0.01 in 2021, then increased by 0.0% to -$0.01 in 2022, then dropped by 0.0% to -$0.01 in 2023, then tumbled by 4300.0% to -$0.44 in 2024, then surged by 45.45% to -$0.24 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.24, -$0.3, and -$0.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.